AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -16.5% | 5,600 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $309,000 | +6.9% | 5,600 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $289,000 | +18.9% | 5,600 | 0.0% | 0.02% | +13.3% |
| Q4 2020 | $243,000 | -18.7% | 5,600 | 0.0% | 0.02% | -37.5% |
| Q2 2020 | $299,000 | +12.0% | 5,600 | 0.0% | 0.02% | +26.3% |
| Q4 2019 | $267,000 | -4.3% | 5,600 | 0.0% | 0.02% | -13.6% |
| Q2 2019 | $279,000 | -26.2% | 5,600 | 0.0% | 0.02% | -29.0% |
| Q1 2019 | $378,000 | +46.5% | 5,600 | 0.0% | 0.03% | +29.2% |
| Q4 2018 | $258,000 | -40.3% | 5,600 | 0.0% | 0.02% | -31.4% |
| Q3 2018 | $432,000 | -8.5% | 5,600 | 0.0% | 0.04% | -12.5% |
| Q2 2018 | $472,000 | +3.1% | 5,600 | 0.0% | 0.04% | -2.4% |
| Q1 2018 | $458,000 | +43.1% | 5,600 | 0.0% | 0.04% | +41.4% |
| Q4 2017 | $320,000 | – | 5,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |